HIGHLIGHTS
- who: Yuqin Zeng and colleagues from the Participants This study enrolled cases of COPD and control volunteers from the Second Xiangya Hospital of Central South University in ChinaThe study was approved by an institutional review board from the Second Xiangya Hospital of Central South University. Written informed consent was obtained from all participants. Thirty stable COPD patients (defined as a postbronchodilator FEV1/FVC andlt have published the Article: PECAM EMPs regulate apoptosis in pulmonary microvascular endothelial cells in COPD by activating the Akt signaling pathway, in the Journal: (JOURNAL)
SUMMARY
VE-cadherin EMPs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.